Toggle Main Menu Toggle Search

Open Access padlockePrints

Invasive coronary function testing in clinical practice: Implementing the 2024 ESC guidelines on chronic coronary syndromes

Lookup NU author(s): Professor Vijay KunadianORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2025 The Authors. Angina with non-obstructive coronary arteries (ANOCA) is increasingly recognized as a significant aspect of chronic coronary syndromes. These patients frequently experience recurrent angina, resulting in high healthcare costs and impaired quality of life. Invasive coronary function testing (ICFT) is able to identify ANOCA endotypes, which can guide treatment and improve quality of life. Despite Class II recommendations for invasive microvascular assessments in the previous 2019 European Society of Cardiology (ESC) Guidelines, ICFT has yet to translate into widespread clinical practice. Patients with ANOCA experience poor quality of life and reduced functional capacity, highlighting the need for earlier ICFT implementation. The 2024 ESC Guidelines now strongly recommend ICFT (Class I, level of evidence B) for patients with non-obstructive coronary arteries and persistent angina despite optimal medical therapy, and for confirming or excluding ANOCA in patients with uncertain diagnoses on non-invasive testing (Class I, level of evidence B). Consequently, a standardized approach to optimize the management of ANOCA patients is warranted. Therefore, this review aims to provide interventional cardiologists with a contemporary review of the literature and a practical guideline on implementation of ICFT. It will discuss the following subjects: the definitions of the different endotypes, an example of an ICFT protocol, discontinuation of medication prior to ICFT, use of radial cocktail, target vessel for testing, acetylcholine injection techniques and rechallenge, adenosine injection techniques, the order of testing, the interpretation of ICFT, safety and feasibility, and the pharmacological treatment.


Publication metadata

Author(s): Namba HF, Boerhout CKM, Damman P, Kunadian V, Escaned J, Ong P, Perera D, Berry C, van de Hoef TP, Piek JJ

Publication type: Article

Publication status: Published

Journal: International Journal of Cardiology

Year: 2025

Volume: 430

Print publication date: 01/07/2025

Online publication date: 22/03/2025

Acceptance date: 17/03/2025

Date deposited: 09/04/2025

ISSN (print): 0167-5273

ISSN (electronic): 1874-1754

Publisher: Elsevier Ireland Ltd

URL: https://doi.org/10.1016/j.ijcard.2025.133176

DOI: 10.1016/j.ijcard.2025.133176


Altmetrics

Altmetrics provided by Altmetric


Share